Inventor · disambiguated record
Dilbir S. Bindra
Also filed as: BINDRA DILBIR · BINDRA DILBIR S · BINDRA DILBIR SINGH
9 granted patents·4 pending applications·1,928 citations·filing 1991–2022
90Inventor score
Top patents by PatentIndex Score
13 records- 0196US7851502B2Pharmaceutical formulations containing an SGLT2 inhibitorBRISTOL MYERS SQUIBB CO·Filed 2008·Granted Dec 14, 2010·57 cites·6 claims
- 0294US5165407AImplantable glucose sensorUNIV KANSAS·Filed 1991·Granted Nov 24, 1992·1.8k cites·9 claims
- 0389US8361972B2Pharmaceutical formulations containing an SGLT2 inhibitorBRISTOL MYERS SQUIBB CO·Filed 2012·Granted Jan 29, 2013·10 cites·22 claims
- 0487US9198925B2Pharmaceutical formulations containing an SGLT2 inhibitorASTRAZENECA AB·Filed 2014·Granted Dec 1, 2015·7 cites·16 claims
- 0587US8716251B2Pharmaceutical formulations containing an SGLT2 inhibitorBRISTOL MYERS SQUIBB CO·Filed 2013·Granted May 6, 2014·8 cites·38 claims
- 0686US8221786B2Pharmaceutical formulations containing an SGLT2 inhibitorBINDRA DILBIR S·Filed 2010·Granted Jul 17, 2012·10 cites·13 claims
- 0779US5733907AProdrugs of an inhibitor of HIV proteaseMERCK & CO INC·Filed 1996·Granted Mar 31, 1998·24 cites·5 claims
- 0864US9233948B2Pharmaceutical compositions comprising N-(4-(2-amino-3-chloropyridin-4-yloxy)-3-fluorophenyl)-4-ethoxy-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamideBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Jan 12, 2016·1 cites·1 claims
- 0956US2025332251A1Use of sucrose, mannitol and glycine to reduce reconstitution time of high concentration lyophilized biologics drug productsBRISTOL MYERS SQUIBB CO·Filed 2022·Application pending·0 cites
- 1050US2013296325A1HIGH DRUG LOAD TABLET FORMULATION OF [(1R), 2S]-2-AMINOPROPIONIC ACID 2-[4-(4-FLUORO-2-METHYL-1H-INDOL-5-YLOXY)-5-METHYLPYRROLO[2,1-f][1,2,4]TRIAZIN-6-YLOXY]-1-METHYLETHYL ESTERNARANG AJIT S·Filed 2012·Application pending·0 cites
- 1147US2015297603A1HIGH DRUG LOAD TABLET FORMULATION OF [(1R), 2S]-2-AMINOPROPIONIC ACID 2-[4-(4-FLUORO-2-METHYL-1H-INDOL-5-YLOXY)-5-METHYLPYRROLO[2,1-f][1,2,4]TRIAZIN-6-YLOXY]-1-METHYLETHYL ESTERBRISTOL MYERS SQUIBB CO·Filed 2015·Application pending·0 cites
- 1243US8911785B2Pharmaceutical compositions comprising N-(4-(2-amino-3-chloropyridin-4-yloxy)-3-fluorophenyl)-4-ethoxy-1-(4-fluorophenyl)-2-OXO-1,2-dihydropyridine-3-carboxamideBINDRA DILBIR S·Filed 2011·Granted Dec 16, 2014·0 cites·10 claims
- 1338US2015119317A1Oral solid dosage formulation of 1,1-dimethylethyl [(1s)-1-carbamoyl)pyrrolidin-1-yl]carbonyl}-2,2-dimethylpropyl]carbamateBRISTOL MYERS SQUIBB CO·Filed 2013·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →